Key terms
About IRTC
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest IRTC news
May 06
12:20pm ET
Citi does not see Apple AF detection tool replacing iRhythm
May 06
7:15am ET
Truist Financial Releases a Buy Rating on Irhythm Technologies (IRTC)
May 04
2:00am ET
Irhythm Technologies’ Capped Call Transactions: A Double-Edged Sword for Stock Stability?
May 03
8:43am ET
iRhythm price target lowered to $122 from $133 at Canaccord
May 03
8:11am ET
Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Lexicon Pharmaceuticals (LXRX)
May 03
8:11am ET
Oppenheimer Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)
May 03
6:58am ET
iRhythm Technologies: Strong Q1 Performance and Growth Potential Justify Buy Rating
May 03
6:53am ET
Irhythm Technologies: A Strong Buy on Robust Growth and Strategic Expansion
May 03
6:38am ET
Irhythm Technologies: A Strong Buy on Robust Q1 Performance and Upward Revenue Guidance
May 03
5:25am ET
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Zura Bio (ZURA)
May 02
4:45pm ET
iRhythm sees FY24 revenue $578M-$588M, consensus $580.81M
May 02
4:43pm ET
iRhythm reports Q1 adjusted EPS ($1.23), consensus (98c)
Mar 10
5:31pm ET
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Mar 05
5:01am ET
Analysts’ Top Healthcare Picks: Avidity Biosciences (RNA), Irhythm Technologies (IRTC)
Mar 04
6:49am ET
iRhythm files to sell $450M of convertible senior notes due 2029
Feb 29
4:57pm ET
iRhythm partners with Epic for Zio access
Feb 28
6:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Irhythm Technologies (IRTC), Ventyx Biosciences (VTYX) and Rewalk Robotics (LFWD)
Feb 28
6:19am ET
iRhythm price target raised to $135 from $125 at Wells Fargo
Feb 28
5:50am ET
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)
Feb 23
7:46am ET
Irhythm Technologies: Poised for Growth Despite Challenges
Feb 23
7:19am ET
iRhythm price target raised to $133 from $121 at Canaccord
Feb 23
6:35am ET
iRhythm price target raised to $135 from $125 at Baird
Feb 23
6:01am ET
Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Eli Lilly & Co (LLY) and Irhythm Technologies (IRTC)
Feb 23
5:40am ET
Analysts Are Bullish on Top Healthcare Stocks: Veracyte (VCYT), Irhythm Technologies (IRTC)
Feb 22
4:19pm ET
iRhythm sees FY24 revenue $575M-$585M, consensus $581.06M
Feb 22
4:18pm ET
iRhythm reports Q4 EPS (84c), consensus (60c)
Feb 07
2:35pm ET
SHAREHOLDER ALERT: Potential Recovery for iRhythm Technologies, Inc. (IRTC) Investors
Yesterday
3:23pm ET
Notice: Grabar Law Office Investigates Claims on Behalf of iRhythm Technologies, Inc. (IRTC) Shareholders Who Have Held Shares Since Prior to January 11, 2022
Apr 12
1:54pm ET
Attention iRhythm Technologies, Inc. (IRTC) Shareholders: Grabar Law Office Investigates Claims on Your Behalf
Apr 08
7:30pm ET
Investors who lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class Action - IRTC
Apr 08
1:43pm ET
24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Apr 08
1:00pm ET
Levi & Korsinsky Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTC
Apr 08
11:45am ET
Class Action Filed Against iRhythm Technologies, Inc. (IRTC) Seeking Recovery for Investors - Contact Levi & Korsinsky
Apr 08
6:35am ET
Contact Levi & Korsinsky by April 8, 2024 Deadline to Join Class Action Against iRhythm Technologies, Inc. (IRTC)
Apr 08
6:00am ET
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
Apr 08
4:40am ET
Levi & Korsinsky Reminds iRhythm Technologies, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 8, 2024 - IRTC
Apr 07
10:00am ET
IRTC FINAL DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Apr 07
9:41am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Apr 06
10:16am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC
Apr 06
9:25am ET
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Apr 04
3:30pm ET
IRTC DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Apr 03
3:28pm ET
IRTC IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Apr 02
9:18pm ET
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Apr 01
8:04pm ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Apr 01
4:21pm ET
IRTC DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 31
4:16pm ET
IRTC IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 31
9:14am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 29
5:42pm ET
IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Alerts iRhythm Technologies, Inc. (IRTC) Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
Mar 29
4:13pm ET
IRTC DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 29
8:17am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC
Mar 28
12:09pm ET
IRTC DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 26
9:21pm ET
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 26
12:50pm ET
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
Mar 25
9:41am ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 25
6:00am ET
IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Notifies iRhythm Technologies, Inc. (IRTC) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Mar 24
9:22am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Mar 21
11:49am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC
Mar 20
5:14pm ET
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC
IRTC Financials
Key terms
Ad Feedback
IRTC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
IRTC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range